Researchers have developed a sensitive CAR-T therapy that targets 'faint' proteins in solid tumors, potentially transforming ...
A growing body of research suggests that GLP-1 drugs do more than control appetite and blood sugar. They could also fight ...
Glucagon-like peptide-1 receptor agonists, known as GLP-1 drugs, are highly effective at helping people lose weight and ...
The American Diabetes Association’s 2026 Standards of Care reframe type 2 diabetes as a multi-system condition, integrating cardiovascular, kidney, and metabolic risk management. The guidelines ...
SGLT2 inhibitors show strong kidney and heart benefits GLP-1 receptor agonists expand role in CKD Insulin’s evolving role in the GLP-1 era Guidelines reflect shift to organ-protective strategies SGLT2 ...
20hon MSN
UK surgeon explains the benefits of starting meals with bitter compounds: ‘Helps prime digestion…’
Starting meals with bitter foods provides multiple digestive benefits. Dr Karan Rajan elaborates upon what they are.
Anifrolumab-fnia, an IFNAR1-blocking monoclonal antibody, is now authorized for weekly subcutaneous self-administration in ...
AstraZeneca’s SAPHNELO ® (anifrolumab-fnia) has been approved in the US for self-administration as a once-weekly autoinjector ...
AstraZeneca's Saphnelo (anifrolumab) has been approved in the US for self-administration as a once-weekly autoinjector, the Saphnelo Pen, for the ...
THE VIBRANT city of London, UK, set the stage for Europe’s leading urological gathering this year: the 41st Annual European ...
Type 2 diabetes is a growing health problem around the world. it develops slowly over time and can lead to serious ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results